Luis Laos, MD
Pulmonary Disease · Orange Park, FLNPI 1407815525
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,700 of the $52,645 with a category attached, or 88.7%. GSK accounts for 93.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $14,332 and has fallen 98.4% since, to $229 in 2025. Among pulmonary disease clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $741.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$49K
- Covidien LP$879
- Johnson & Johnson$607
- Viiv Healthcare Company$600
- Medical Device Business Services, Inc.$507
- Veran Medical Technologies, Inc.$280
- plus $607 from 8 others
What the payments were for
- Speaking & faculty fees$46,70089%
- Travel & lodging$3,2646%
- Food & beverage$2,6815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 43 | $49,165 |
| Covidien LP | 5 | $879 |
| Johnson & Johnson | 7 | $607 |
| Viiv Healthcare Company | 1 | $600 |
| Medical Device Business Services, Inc. | 6 | $507 |
| Veran Medical Technologies, Inc. | 1 | $280 |
| Pulse Biosciences, Inc. | 1 | $229 |
| Regeneron Healthcare Solutions, Inc. | 1 | $101 |
| Inspire Medical Systems, Inc. | 1 | $86 |
| Baxter Healthcare | 1 | $65 |
| Boehringer Ingelheim | 1 | $60 |
| AbbVie | 1 | $23 |
| Abbott | 1 | $22 |
| Vapotherm Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$37,658
- ANORO$1,096
- superDimension$837
- Monarch Platform$471
- Spin$280
- CellFX$229
- ANORO ELLIPTA$221
- DUPIXENT$101
How this compares
$52,645 in reported general payments places this provider in the 90th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Orange Park
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.